| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/PPUL.1950080311 |
| P698 | PubMed publication ID | 2190148 |
| P2093 | author name string | Zach MS | |
| P2860 | cites work | The role of immune complexes in the pathogenesis of bacterial infections | Q39480111 |
| Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay | Q39614519 | ||
| Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis | Q39714807 | ||
| Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction | Q39846012 | ||
| Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins | Q39855316 | ||
| Clearance of Pseudomonas aeruginosa in different rat lung models | Q41391755 | ||
| Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains | Q41574037 | ||
| Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa | Q44412123 | ||
| IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. | Q54452367 | ||
| P433 | issue | 3 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 188-202 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Pediatric Pulmonology | Q15749800 |
| P1476 | title | Lung disease in cystic fibrosis--an updated concept | |
| P478 | volume | 8 |
| Q30462651 | Airway clearance devices for cystic fibrosis: an evidence-based analysis |
| Q72619790 | Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis |
| Q44913047 | Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung |
| Q51712229 | Changes in pulmonary mechanics with increasing disease severity in children and young adults with cystic fibrosis. |
| Q24187019 | Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis |
| Q24198225 | Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis |
| Q33909810 | Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. |
| Q24245097 | Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis |
| Q24250579 | Conventional chest physiotherapy compared to other forms of chest physiotherapy for cystic fibrosis |
| Q40204073 | Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. |
| Q37178571 | Effects of changes in lung volume on oscillatory flow rate during high-frequency chest wall oscillation |
| Q77362032 | Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study |
| Q35769195 | Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. |
| Q45088964 | Improved lung function and body mass index associated with long-term use of Macrolide antibiotics |
| Q36949104 | Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes |
| Q41127253 | Inhaled antibiotics in cystic fibrosis: a review |
| Q45887687 | Lef1 transcription factor expression defines airway progenitor cell targets for in utero gene therapy of submucosal gland in cystic fibrosis |
| Q30080000 | Lung infections associated with cystic fibrosis |
| Q41474372 | Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis |
| Q24242712 | Nebuliser devices for drug delivery in cystic fibrosis |
| Q24194837 | Oscillating devices for airway clearance in people with cystic fibrosis |
| Q24241016 | Oscillating devices for airway clearance in people with cystic fibrosis |
| Q24243289 | Oscillating devices for airway clearance in people with cystic fibrosis |
| Q38687763 | Oscillating devices for airway clearance in people with cystic fibrosis |
| Q39846673 | Osmoprotectant-dependent expression of plcH, encoding the hemolytic phospholipase C, is subject to novel catabolite repression control in Pseudomonas aeruginosa PAO1. |
| Q70156214 | Pathogenesis and management of lung disease in cystic fibrosis |
| Q24187133 | Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis |
| Q24246145 | Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis |
| Q24247446 | Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis |
| Q40975388 | Positive pressure--analysing the effect of the addition of non-invasive ventilation (NIV) to home airway clearance techniques (ACT) in adult cystic fibrosis (CF) patients. |
| Q74449870 | Pulmonary function in hospitalized infants and toddlers with cystic fibrosis |
| Q33624880 | Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment |
| Q64969505 | Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis. |
| Q39550332 | Rapid detection, identification, and enumeration of Pseudomonas aeruginosa in bottled water using peptide nucleic acid probes |
| Q42209678 | Role of CD 11/CD 18 in neutrophil emigration during acute and recurrent Pseudomonas aeruginosa-induced pneumonia in rabbits. |
| Q71953608 | Role of anticholinergic agents in the treatment of cystic fibrosis |
| Q67581993 | Self-administered chest physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage |
| Q33965577 | Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients |
| Q36496558 | The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems |
| Q35259843 | Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation |
Search more.